Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Long-term data presented on LB-03002 in children with growth hormone deficiency

Sep. 29, 2011

Preliminary findings from IMPACT study made available

Sep. 29, 2011

Recombinant measles vector-based HIV-1 vaccine evaluated in primates

Sep. 29, 2011

Preclinical and first-in-human data presented on NDV-3 candidiasis vaccine

Sep. 29, 2011

Glycopyrrolate formulations show efficacy in randomized phase II trials in COPD

Sep. 28, 2011

Progenics discloses preclinical data on humanized MAbs targeting C. difficile toxins

Sep. 28, 2011

Phase I/II trial investigates polyepitope DNA vaccine in metastatic melanoma

Sep. 28, 2011

Taliglucerase alfa assessed in Gaucher's disease under French AUT program

Sep. 28, 2011

Basilea Pharmaceutica discloses more findings from first-in-human trial of BAL-30072

Sep. 28, 2011

Data disclosed from several trials assessing velaglucerase alfa in type 1 Gaucher's disease

Sep. 28, 2011

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...